Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population : Real-World Use and Early Medication Success

Müllerová, HanaShi Kai Chan, JeffreyHeatley, HeathCarter, VictoriaTownend, JohnSkinner, DerekFranzen, StefanMarshall, JonathanPrice, David2024-05-282024-05-282024-05-24Müllerová, H, Shi Kai Chan, J, Heatley, H, Carter, V, Townend, J, Skinner, D, Franzen, S, Marshall, J & Price, D 2024, 'Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population : Real-World Use and Early Medication Success', International journal of chronic obstructive pulmonary disease , vol. 19, pp. 1153-1166. https://doi.org/10.2147/COPD.S4526241176-9106https://hdl.handle.net/2164/23523We thank Johann Castaneda for his contribution to protocol development, analysis and interpretation of data. Dr Ruth B Murray (Medscript NZ Ltd) provided medical writing assistance under the direction of the authors, funded by AstraZeneca.142599531engdeathexacerbationheart failuremyocardial infarctionpneumoniaR MedicineRBudesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population : Real-World Use and Early Medication SuccessJournal article10.2147/COPD.S45262419